ETH 416 (Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U)
Generic Name: pancrelipase
Pill imprint ETH 416 has been identified as Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U.
Plaretase is used in the treatment of pancreatic exocrine dysfunction; chronic pancreatitis; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- ETH 416
- Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U
- Rx and/or OTC
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Ethex Corporation
- National Drug Code (NDC):
More about Plaretase (pancrelipase)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.